Federal Register / Vol. 83, No. 2 / Wednesday, January 3, 2018 / Notices 385 

Research Misconduct notice published 

on November 27, 2017. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Karen Gorirossi at 240–453–8800. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In FR Doc. 2017–25549 of November 

27, 2017 (82 FR 56042–56043), there 

was a referencing error involving 

incorrect citation of a paper in the 

notice. The error is identified and 

corrected in the Correction of Errors 

section below. 

II. Correction of Errors 

In FR Doc. 2017–25549 of November 

27, 2017 (82 FR 56042–56043), make the 

following corrections: 

1. On page 56042, third column, in FR 

Doc. 2017–25549, last paragraph, lines 

16–26, and page 56043, first paragraph, 

lines 1–5, delete ‘‘Respondent engaged 

in research misconduct at ESOM and 

falsified RT–PCR data on Excel 

spreadsheets in the research record and 

in a figure generated from the false data 

included in a manuscript submitted to 

and withdrawn from Scientific Reports 

(‘‘Immipramine Blue Sensitively and 

Selectively Targets FLT3–ITD Positive 

Acute Myeloid Leukemia Cells.’’ 

Scientific Reports 7(1):4447, 2017 June 

30; doi:10.1038/s41598–017–04796–1. 

PMID: 28667329. Submitted to 

Scientific Reports [withdrawn]; 

hereafter referred to as the ‘‘Scientific 

Reports manuscript’’)’’ and replace with 

the following text: ‘‘Respondent engaged 

in research misconduct at ESOM and 

falsified RT–PCR data on Excel 

spreadsheets in the research record and 

in a figure generated from the false data 

included in an unpublished manuscript 

submitted to and withdrawn from 

Scientific Reports [withdrawn]; 

hereafter referred to as the ‘‘Scientific 

Reports manuscript.’’ ’’ 

2. On page 56043, first column, in FR 

Doc. 2017–25549, fourth paragraph 

(second bullet), lines 6–7, insert 

‘‘unpublished’’ before ‘‘Scientific 

Reports’’ so that the text reads: 

‘‘included false data in the unpublished 

Scientific Reports manuscript.’’ 

Dated: December 20, 2017. 

Wanda K. Jones, 

Interim Director, Office of Research Integrity. 

[FR Doc. 2017–28409 Filed 1–2–18; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

Date: January 24, 2018. 

Open: 8:30 a.m. to 12:00 p.m. 

Agenda: To present the Director’s Report 

and other scientific presentations. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room E1/E2, 45 Center 

Drive, Bethesda, MD 20892. 

Closed: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room E1/E2, 45 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive, and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council, Kidney, Urologic and Hematologic 

Diseases. 

Date: January 24, 2018. 

Open: 1:00 p.m. to 3:30 p.m. 

Agenda: To review the Division’s scientific 

and planning activities. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room F1/F2, 45 Center 

Drive, Bethesda, MD 20892. 

Closed: 3:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room F1/F2, 45 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council; Diabetes, Endocrinology and 

Metabolic Diseases. 

Date: January 24, 2018. 

Open: 1:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate to review 

the Division’s scientific and planning 

activities. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room E1/E2, 45 Center 

Drive, Bethesda, MD 20892. 

Closed: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room E1/E2, 45 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive, and Kidney Diseases, 6707 

Democracy Blvd., Room, 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council; Digestive Diseases and Nutrition. 

Date: January 24, 2018. 

Open: 1:00 p.m. to 2:30 p.m. 

Agenda: To review the Division’s scientific 

and planning activities. 

Place: National Institutes of Health, 

Natcher Building (Natcher Conference 

Center), Conference Room D, 45 Center Drive, 

Bethesda, MD 20892. 

Closed: 2:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place:National Institutes of Health, Natcher 

Building (Natcher Conference Center), 

Conference Room D, 45 Center Drive, 

Bethesda, MD 20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive, and Kidney Diseases, 6707 

Democracy Blvd. Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 


sradovich on DSK3GMQ082PROD with NOTICES
386 Federal Register / Vol. 83, No. 2 / Wednesday, January 3, 2018 / Notices 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.niddk.nih.gov/fund/divisions/DEA/ 

Council/coundesc.htm., where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: December 28, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–28417 Filed 1–2–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Neuroscience of 

Aging Review Committee; NIA—N. 

Date: February 1–2, 2018. 

Time: 8:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, 7201 

Wisconsin Avenue, Gateway Building, Suite 

2W200, Bethesda, MD 20892, 301–402–1622, 

bissonettegb@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 28, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–28415 Filed 1–2–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; PHS 2018—Topic 60: 

Computational Software Development to 

Advance Translational Research for 

Infectious Diseases. 

Date: January 25, 2018. 

Time: 12:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Eleazar Cohen, Ph.D., 

Scientific Review Officer Scientific Review 

Program, Division of Extramural Activities, 

Room 3G62A, National Institute of Health, 

NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–9823, (240) 669–5081, 

ecohen@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; PHS 2018–1: Small Business 

Innovation Research (SBIR) Program Contract 

Solicitation (Topic 52) (N01). 

Date: January 26, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Vasundhara Varthakavi, 

DVM, Ph.D., Scientific Review Officer 

Scientific Review Program, Division of 

Extramural Activities, Room 3E70, National 

Institutes of Health, NIAID, 5601 Fishers 

Lane, MSC 9823, Bethesda, MD 20892–9823, 

(240) 669–5020, varthakaviv@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; (PHS–2016–1) Small 

Business Innovation Research (SBIR) ‘‘Topics 

37 and 38: ‘‘Phase II Program Contract 

Solicitation’’. 

Date: January 26, 2018. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Ellen S. Buczko, Ph.D., 

Scientific Review Officer Scientific Review 

Program, Division of Extramural Activities, 

Room # 3F30A National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–9823, (240) 669–5028, 

ebuczko1@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 26, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–28338 Filed 1–2–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neurodifferentiation, 

Plasticity, Regeneration and Rhythmicity 

Study Section. 

Date: January 30, 2018. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Alexandrian, 480 King Street, 

Alexandria, VA 22314. 


sradovich on DSK3GMQ082PROD with NOTICES